{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:16:20Z","timestamp":1790813780693,"version":"4.1.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Humans are infected by\n                    <jats:italic>Toxoplasma gondii<\/jats:italic>\n                    worldwide and its consequences may seriously affect an immune deprived population such as HIV and transplanted patients or pregnant women and foetuses. A deep knowledge of toxoplasmosis seroprevalence in Spain is needed in order to better shape health policies and educational programs. We present the results of the first systematic review and meta-analysis on the human prevalence for this disease in Spain. Databases (PubMed, Web of Science, SCOPUS and Teseo) were searched for relevant studies that were published between January 1993 and December 2023 and all population-based cross-sectional and longitudinal studies reporting the human seroprevalence in Spain were revised. Within the population analysed, our targeted groups were immunocompetent population, pregnant women and immunocompromised patients. Among 572 studies and 35 doctoral theses retrieved, 15 studies and three doctoral theses were included in the meta-analysis. A random effects model was used for the meta-analyses due to the high heterogeneity found between studies (\n                    <jats:italic>I<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    : 99.97), since it is a statistically conservative model, in addition to allowing better external validity. The global pooled seroprevalence was 32.3% (95% CI 28.7\u201336.2%). Most of the studies carried out were in pregnant women and the meta-analysis reported that the pooled seroprevalence of toxoplasmosis in pregnant women in Spain was 24.4% (24,737\/85,703, 95% CI 21.2\u201328.0%), based on the random effects model. It is recommended to continue monitoring the seroprevalence status of\n                    <jats:italic>T. gondii<\/jats:italic>\n                    in order to obtain essential guidelines for the prevention and control of the infection in the population.\n                  <\/jats:p>","DOI":"10.1007\/s44197-024-00258-w","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T02:01:40Z","timestamp":1718157700000},"page":"621-637","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prevalence of Human Toxoplasmosis in Spain Throughout the Three Last Decades (1993\u20132023): A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3689-3468","authenticated-orcid":false,"given":"Mariola","family":"Miguel-Vicedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3639-5951","authenticated-orcid":false,"given":"Paula","family":"Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5651-1262","authenticated-orcid":false,"given":"M. Carmen","family":"Ortega-Navas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5083-8854","authenticated-orcid":false,"given":"David","family":"Gonz\u00e1lez-Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3605-6252","authenticated-orcid":false,"given":"Isabel","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"issue":"1","key":"258_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-3305-3-112","volume":"3","author":"JP Webster","year":"2010","unstructured":"Webster JP, Dubey JP. Toxoplasmosis of animals and humans. Parasites Vectors. 2010;3(1):1\u20132. https:\/\/doi.org\/10.1186\/1756-3305-3-112.","journal-title":"Parasites Vectors."},{"key":"258_CR2","doi-asserted-by":"publisher","unstructured":"Aguirre AA, Longcore T, Barbieri M, Dabritz H, Hill D, Klein PN, et al. the one health approach to toxoplasmosis: epidemiology, control, and prevention strategies. Ecohealth. 16. https:\/\/doi.org\/10.1007\/s10393-019-01405-7","DOI":"10.1007\/s10393-019-01405-7"},{"key":"258_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/J.ACTATROPICA.2022.106432","author":"RAM de Barros","year":"2022","unstructured":"de Barros RAM, Torrecilhas AC, Marciano MAM, Mazuz ML, Pereira-Chioccola VL, Fux B. Toxoplasmosis in human and animals around the world. Diagnosis and perspectives in the one health approach. Acta Trop. 2022. https:\/\/doi.org\/10.1016\/J.ACTATROPICA.2022.106432.","journal-title":"Acta Trop"},{"issue":"4","key":"258_CR4","first-page":"898","volume":"36","author":"A Molan","year":"2019","unstructured":"Molan A, Nosaka K, Hunter M, Wang. Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots. Trop Biomed. 2019;36(4):898\u2013925.","journal-title":"Trop Biomed"},{"key":"258_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/S13071-020-04445-Z","author":"M Attias","year":"2020","unstructured":"Attias M, Teixeira DE, Benchimol M, Vommaro RC, Crepaldi PH, De Souza W. The life-cycle of Toxoplasma gondii reviewed using animations. Parasit Vectors. 2020. https:\/\/doi.org\/10.1186\/S13071-020-04445-Z.","journal-title":"Parasit Vectors"},{"issue":"2","key":"258_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1128\/CMR.11.2.267","volume":"11","author":"JP Dubey","year":"1998","unstructured":"Dubey JP, Lindsay DS, Speer CA. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev. 1998;11(2):267\u201399. https:\/\/doi.org\/10.1128\/CMR.11.2.267.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"258_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/CLINIDS\/15.2.211","volume":"15","author":"BJ Luft","year":"1992","unstructured":"Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992;15(2):211\u201322. https:\/\/doi.org\/10.1093\/CLINIDS\/15.2.211.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"258_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/PATHOGENS12040543","volume":"12","author":"J Layton","year":"2023","unstructured":"Layton J, Theiopoulou DC, Rutenberg D, Elshereye A, Zhang Y, Sinnott J, et al. Clinical spectrum, radiological findings, and outcomes of severe toxoplasmosis in immunocompetent hosts: a systematic review. Pathog. 2023;12(4):543. https:\/\/doi.org\/10.3390\/PATHOGENS12040543.","journal-title":"Pathog"},{"key":"258_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/J.NEUBIOREV.2018.11.012","volume":"96","author":"S Tyebji","year":"2019","unstructured":"Tyebji S, Seizova S, Hannan AJ, Tonkin CJ. Toxoplasmosis: A pathway to neuropsychiatric disorders. Neurosci Biobehav Rev. 2019;96:72\u201392. https:\/\/doi.org\/10.1016\/J.NEUBIOREV.2018.11.012.","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"258_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1319","volume":"6","author":"H Bisetegn","year":"2023","unstructured":"Bisetegn H, Debash H, Ebrahim H, Mahmood N, Gedefie A, Tilahun M, Alemayehu E, Mohammed O, Feleke DG. Global seroprevalence of Toxoplasma gondii infection among patients with mental and neurological disorders: a systematic review and meta-analysis. Health Sci Rep. 2023;6(6): e1319. https:\/\/doi.org\/10.1002\/hsr2.1319.","journal-title":"Health Sci Rep"},{"issue":"2","key":"258_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0297523","volume":"19","author":"D Rosado","year":"2024","unstructured":"Rosado D, Intriago B, Loor E, Alc\u00edvar F, Avila J, Sotomayor M, Villacres L, Faytong-Haro M. Associations between Toxoplasma gondii seropositivity and psychopathological manifestations in schizophrenic patients: a single-center study from Ecuador. PLoS ONE. 2024;19(2): e0297523. https:\/\/doi.org\/10.1371\/journal.pone.0297523.","journal-title":"PLoS ONE"},{"issue":"1","key":"258_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/20477724.2022.2083977","volume":"117","author":"S Dian","year":"2023","unstructured":"Dian S, Ganiem AR, Ekawardhani S. Cerebral toxoplasmosis in HIV-infected patients: a review. Pathog Glob Health. 2023;117(1):14\u201323. https:\/\/doi.org\/10.1080\/20477724.2022.2083977.","journal-title":"Pathog Glob Health."},{"key":"258_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13071-015-0902-6","volume":"8","author":"Q Liu","year":"2015","unstructured":"Liu Q, Wang ZD, Huang SY, Zhu XQ. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors. 2015;8:292. https:\/\/doi.org\/10.1186\/s13071-015-0902-6.","journal-title":"Parasit Vectors"},{"key":"258_CR14","unstructured":"European Centre for Disease Prevention and Control. Congenital toxoplasmosis. In: ECDC. Annual Epidemiological Report for 2020. Stockholm: ECDC; 2023."},{"issue":"9425","key":"258_CR15","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya JG, Liesenfeld O. Toxoplasmosis Lancet. 2004;363(9425):1965\u201376. https:\/\/doi.org\/10.1016\/S0140-6736(04)16412-X.","journal-title":"Toxoplasmosis Lancet"},{"issue":"1","key":"258_CR16","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1186\/s12879-021-06497-7","volume":"21","author":"A Amare","year":"2021","unstructured":"Amare A. Seizure in HIV-infected patients: clinical presentation, cause and treatment outcome in Ethiopia-a retrospective study. BMC Infect Dis. 2021;21(1):790. https:\/\/doi.org\/10.1186\/s12879-021-06497-7.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"258_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/tropicalmed8010003","volume":"8","author":"M Deganich","year":"2022","unstructured":"Deganich M, Boudreaux C, Benmerzouga I. Toxoplasmosis Infection during Pregnancy. Trop Med Infect Dis. 2022;8(1):3. https:\/\/doi.org\/10.3390\/tropicalmed8010003.","journal-title":"Trop Med Infect Dis"},{"key":"258_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/BMJ.N71","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:372. https:\/\/doi.org\/10.1136\/BMJ.N71.","journal-title":"BMJ"},{"key":"258_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/S13643-016-0384-4","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016. https:\/\/doi.org\/10.1186\/S13643-016-0384-4.","journal-title":"Syst Rev"},{"key":"258_CR20","doi-asserted-by":"publisher","DOI":"10.11124\/JBISRIR-D-19-00099","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020. https:\/\/doi.org\/10.11124\/JBISRIR-D-19-00099.","journal-title":"JBI Evid Synth."},{"issue":"5","key":"258_CR21","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/S00436-011-2393-5\/FIGURES\/1","volume":"109","author":"JM Ramos","year":"2011","unstructured":"Ramos JM, Milla A, Rodr\u00edguez JC, Padilla S, Masi\u00e1 M, Guti\u00e9rrez F. Seroprevalence of Toxoplasma gondii infection among immigrant and native pregnant women in Eastern Spain. Parasitol Res. 2011;109(5):1447\u201352. https:\/\/doi.org\/10.1007\/S00436-011-2393-5\/FIGURES\/1.","journal-title":"Parasitol Res"},{"issue":"10","key":"258_CR22","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.eimc.2010.04.007","volume":"28","author":"A Sampedro","year":"2010","unstructured":"Sampedro A, Mazuelas P, Rodrguez-Granger J, Torres E, Puertas A, Navarro JM. Marcadores serol\u00f3gicos en gestantes inmigrantes y aut\u00f3ctonas en Granada. Enferm Infecc Microbiol Clin. 2010;28(10):694\u20137.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"9","key":"258_CR23","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/s0213-005x(04)73152-3","volume":"22","author":"N Guti\u00e9rrez-Zufiaurre","year":"2004","unstructured":"Guti\u00e9rrez-Zufiaurre N, S\u00e1nchez-Hern\u00e1ndez J, Mu\u00f1oz S, Mar\u00edn R, Delgado N, Carmen SM, et al. Seroprevalencia de anticuerpos frente a Treponema pallidum, Toxoplasma gondii, virus de la rub\u00e9ola, virus de la hepatitis B y C y VIH en mujeres gestantes. Enferm Infecc Microbiol Clin. 2004;22(9):512\u20136. https:\/\/doi.org\/10.1016\/s0213-005x(04)73152-3.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"1","key":"258_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/s0025-7753(04)74396-1","volume":"123","author":"C Mu\u00f1oz Batet","year":"2004","unstructured":"Mu\u00f1oz Batet C, Guardi\u00e0 Llobet C, Juncosa Morros T, Vi\u00f1as Domenech L, Sierra Soler M, Sanfeliu Sala I, et al. Toxoplasmosis y embarazo. Estudio multic\u00e9ntrico realizado en 16.362 gestantes de Barcelona. Med Clin (Barc). 2004;123(1):12\u20136. https:\/\/doi.org\/10.1016\/s0025-7753(04)74396-1.","journal-title":"Med Clin (Barc)"},{"issue":"3","key":"258_CR25","first-page":"151","volume":"16","author":"C Guerra Garc\u00eda","year":"1995","unstructured":"Guerra Garc\u00eda C, Fern\u00e1ndez Sampedro J. Seroprevalencia de Toxoplasma gondii.pdf. Aten primaria. 1995;16(3):151\u20133.","journal-title":"Aten primaria"},{"issue":"8","key":"258_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.eimc.2009.11.004","volume":"28","author":"ML Roc","year":"2010","unstructured":"Roc ML, Palacin MP, Lomba E, Monforte ML, Rebaje V, Revillo Pinilla MJ. Diagn\u00f3stico serol\u00f3gico de los casos de toxoplasmosis cong\u00e9nita. Enferm Infecc Microbiol Clin. 2010;28(8):517\u20139.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"2","key":"258_CR27","first-page":"108","volume":"26","author":"F L\u00f3pez-Fabal","year":"2013","unstructured":"L\u00f3pez-Fabal F, G\u00f3mez-Garc\u00e9s JL. Marcadores serol\u00f3gicos de gestantes espa\u00f1olas e inmigrantes en un \u00e1rea del sur de Madrid durante el periodo 2007\u20132010. Rev Esp Quimioter. 2013;26(2):108\u201311.","journal-title":"Rev Esp Quimioter"},{"issue":"2","key":"258_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.eimc.2011.07.010","volume":"30","author":"B Santiago","year":"2012","unstructured":"Santiago B, Bl\u00e1zquez D, L\u00f3pez G, Sainz T, Mu\u00f1oz M, Alonso T, et al. Perfil serol\u00f3gico en gestantes extranjeras frente a VIH, VHB, VHC, virus de la rub\u00e9ola, Toxoplasma gondii, Treponema pallidum, y Trypanosoma cruzi. Enferm Infecc Microbiol Clin. 2012;30(2):64\u20139.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"258_CR29","volume-title":"Desarrollo De T\u00e9cnicas De ADN Para El Diagn\u00f3stico Y Caracterizaci\u00f3n De \u201cToxoplasma gondii\u201d: Aplicaci\u00f3n a Estudios Epidemiol\u00f3gicos","author":"I Fuentes","year":"2005","unstructured":"Fuentes I. Desarrollo De T\u00e9cnicas De ADN Para El Diagn\u00f3stico Y Caracterizaci\u00f3n De \u201cToxoplasma gondii\u201d: Aplicaci\u00f3n a Estudios Epidemiol\u00f3gicos. Madrid: Servicio de Publicaciones Universidad Complutense; 2005."},{"issue":"8","key":"258_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.eimc.2012.01.009","volume":"30","author":"J Llenas-Garc\u00eda","year":"2012","unstructured":"Llenas-Garc\u00eda J, Rubio R, Hernando A, Fiorante S, Maseda D, Matarranz M, et al. Caracter\u00edsticas cl\u00ednico-epidemiol\u00f3gicas de los pacientes inmigrantes con infecci\u00f3n por el VIH: estudio de 371 casos. Enferm Infecc Microbiol Clin. 2012;30(8):441\u201351.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"4","key":"258_CR31","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/00002030-200003100-00011","volume":"14","author":"V Soriano","year":"2000","unstructured":"Soriano V, Dona C, Rodr\u00edguez-Rosado R, Barreiro P, Gonz\u00e1lez-Lahoz J. Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy. AIDS. 2000;14(4):383\u20136.","journal-title":"AIDS"},{"issue":"9","key":"258_CR32","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1086\/374358","volume":"36","author":"FJ San-Andr\u00e9s","year":"2003","unstructured":"San-Andr\u00e9s FJ, Rubio R, Castilla J, Pulido F, Palao G, De Pedro I, et al. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989\u20131997. Clin Infect Dis. 2003;36(9):1177\u201385.","journal-title":"Clin Infect Dis"},{"key":"258_CR33","first-page":"246","volume":"106","author":"J Castilla","year":"1996","unstructured":"Castilla J, Guti\u00e9rrez A, Ramos B, Camarero M, Burgoa M, Noguera I. Patr\u00f3n de las enfermedades diagn\u00f3sticas de sida en adultos y adolescentes en Espa\u00f1a, 1988\u20131993. Med Clin. 1996;106:246\u201350.","journal-title":"Med Clin"},{"issue":"10","key":"258_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0025-7753(00)71564-8","volume":"115","author":"M Pujol-Riqu\u00e9","year":"2000","unstructured":"Pujol-Riqu\u00e9 M, Quint\u00f3 L, Dan\u00e9s C, Valls ME, Coll O, Jim\u00e9nez De Anta MT. Seroprevalencia de la toxoplasmosis en mujeres en edad f\u00e9rtil (1992\u20131999). Med Clin (Barc). 2000;115(10):375\u20136. https:\/\/doi.org\/10.1016\/S0025-7753(00)71564-8.","journal-title":"Med Clin (Barc)"},{"issue":"2","key":"258_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.7883\/yoken.JJID.2014.181","volume":"68","author":"MA Asencio","year":"2015","unstructured":"Asencio MA, Herraez O, Tenias JM, Gardu\u00e3o E, Huertas M, Carranza R, et al. Seroprevalence survey of zoonoses in extremadura, southwestern Spain, 2002\u20132003. Jpn J Infect Dis. 2015;68(2):106\u201312.","journal-title":"Jpn J Infect Dis"},{"key":"258_CR36","first-page":"224","volume":"16","author":"F del Castillo","year":"1998","unstructured":"del Castillo F, Herrero R. Factores de riesgo de toxoplasmosis en el ni\u00f1o. Enferm Infecc Microbiol Clin. 1998;16:224\u2013229.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"3","key":"258_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1590\/S1135-57272008000300009","volume":"82","author":"J Bartolom\u00e9 \u00c1lvarez","year":"2008","unstructured":"Bartolom\u00e9 \u00c1lvarez J, Serrano MM, Parrado LM, Ortu\u00f1o SL, S\u00e1nchez MDC. Prevalencia e incidencia de la infecci\u00f3n por Toxoplasma gondii en mujeres en edad f\u00e9rtil en Albacete (2001\u20132007). Rev Esp Salud Publica. 2008;82(3):333\u201342.","journal-title":"Rev Esp Salud Publica"},{"key":"258_CR38","unstructured":"G\u00f3mez i Grau F. Estudio sobre la toxoplasmosis en Andorra y el Alt Urgell. TDX (Tesis Dr en Xarxa). 2005;"},{"key":"258_CR39","unstructured":"Rodr\u00edguez Ponce E. Seroprevalencia de la toxoplasmosis en las especies humana, caprina y bovina en Gran Canaria. 1994;"},{"issue":"1","key":"258_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3201\/EID1701.P11101","volume":"17","author":"E Scallan","year":"2011","unstructured":"Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, et al. Foodborne illness acquired in the United States\u2013major pathogens. Emerg Infect Dis. 2011;17(1):7\u201315. https:\/\/doi.org\/10.3201\/EID1701.P11101.","journal-title":"Emerg Infect Dis"},{"key":"258_CR41","doi-asserted-by":"publisher","unstructured":"Guarch-Ib\u00e1\u00f1ez B, Carreras-Abad C, Frick MA, Bl\u00e1zquez-Gamero D, Baquero-Artigao F, Fuentes I, et al. Resultados de la encuesta nacional de REIV-TOXO sobre el cribado gestacional de la toxoplasmosis en Espa\u00f1a. Enferm Infecc Microbiol Clin. 2023.  https:\/\/doi.org\/10.1016\/j.eimc.2023.08.004","DOI":"10.1016\/j.eimc.2023.08.004"},{"key":"258_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/BMJOPEN-2019-033995","author":"AA Sandoval-Carrillo","year":"2020","unstructured":"Sandoval-Carrillo AA, V\u00e9rtiz-Hern\u00e1ndez AA, Salas-Pacheco JM, Gonz\u00e1lez-Lugo OE, Antuna-Salcido EI, Salas-Pacheco SM, et al. Original research: Toxoplasma gondii infection in pregnant women: a cross-sectional study in Matehuala City, Mexico. BMJ Open. 2020. https:\/\/doi.org\/10.1136\/BMJOPEN-2019-033995.","journal-title":"BMJ Open"},{"key":"258_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/FCIMB.2021.783654","author":"F Mao","year":"2021","unstructured":"Mao F, Yang Y, Chen Y, Zhang Q, Ding X, Ni B, et al. Seroprevalence and risk factors of Toxoplasma gondii infection among high-risk populations in Jiangsu Province. Eastern China Front Cell Infect Microbiol. 2021. https:\/\/doi.org\/10.3389\/FCIMB.2021.783654.","journal-title":"Eastern China. Front Cell Infect Microbiol."},{"issue":"1","key":"258_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13071-016-1432-6\/FIGURES\/1","volume":"9","author":"C Yan","year":"2016","unstructured":"Yan C, Liang LJ, Zheng KY, Zhu XQ. Impact of environmental factors on the emergence, transmission and distribution of Toxoplasma gondii. Parasit Vectors. 2016;9(1):1\u20137. https:\/\/doi.org\/10.1186\/S13071-016-1432-6\/FIGURES\/1.","journal-title":"Parasit Vectors"},{"key":"258_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/MICROORGANISMS9112346","author":"G \u00c1lvarez Garc\u00eda","year":"2021","unstructured":"\u00c1lvarez Garc\u00eda G, Davidson R, Jokelainen P, Klevar S, Spano F, Seeber F. Identification of oocyst-driven Toxoplasma gondii infections in humans and animals through stage-specific serology-current status and future perspectives. Microorganisms. 2021. https:\/\/doi.org\/10.3390\/MICROORGANISMS9112346.","journal-title":"Microorganisms."},{"key":"258_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2018.02369","author":"N Guigue","year":"2018","unstructured":"Guigue N, L\u00e9on L, Hamane S, Gits-Muselli M, Le Strat Y, Alanio A, et al. Continuous decline of Toxoplasma gondii Seroprevalence in Hospital: a 1997\u20132014 longitudinal study in Paris. France Front Microbiol. 2018. https:\/\/doi.org\/10.3389\/FMICB.2018.02369.","journal-title":"France. Front Microbiol."},{"key":"258_CR47","doi-asserted-by":"publisher","DOI":"10.1051\/PARASITE\/2020057","author":"AG Mihu","year":"2020","unstructured":"Mihu AG, Balta C, Marti DT, Paduraru AA, Lupu MA, Olariu TR. Seroprevalence of Toxoplasma gondii infection among women of childbearing age in an endemic region of Romania, 2016\u20132018. Parasite. 2020. https:\/\/doi.org\/10.1051\/PARASITE\/2020057.","journal-title":"Parasite"},{"key":"258_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0090203","author":"J Flegr","year":"2014","unstructured":"Flegr J, Prandota J, Sovi\u010dkov\u00e1 M, Israili ZH. Toxoplasmosis\u2013a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS ONE. 2014. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0090203.","journal-title":"PLoS ONE"},{"issue":"25","key":"258_CR49","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3238\/ARZTEBL.2019.0435","volume":"116","author":"U Pleyer","year":"2019","unstructured":"Pleyer U, Gro\u00df U, Schl\u00fcter D, Wilking H, Seeber F. Toxoplasmosis in Germany: Epidemiology, Diagnosis, Risk factors, and Treatment. Dtsch Arztebl Int. 2019;116(25):435. https:\/\/doi.org\/10.3238\/ARZTEBL.2019.0435.","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"258_CR50","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/J.VETPAR.2004.08.015","volume":"126","author":"G Mir\u00f3","year":"2004","unstructured":"Mir\u00f3 G, Montoya A, Jim\u00e9nez S, Frisuelos C, Mateo M, Fuentes I. Prevalence of antibodies to Toxoplasma gondii and intestinal parasites in stray, farm and household cats in Spain. Vet Parasitol. 2004;126(3):249\u201355. https:\/\/doi.org\/10.1016\/J.VETPAR.2004.08.015.","journal-title":"Vet Parasitol"},{"key":"258_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/J.VETPAR.2018.01.009","volume":"251","author":"A Montoya","year":"2018","unstructured":"Montoya A, Garc\u00eda M, G\u00e1lvez R, Checa R, Marino V, Sarquis J, et al. Implications of zoonotic and vector-borne parasites to free-roaming cats in central Spain. Vet Parasitol. 2018;251:125\u201330. https:\/\/doi.org\/10.1016\/J.VETPAR.2018.01.009.","journal-title":"Vet Parasitol"},{"issue":"15","key":"258_CR52","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.3390\/ANI13152488","volume":"13","author":"P Matas M\u00e9ndez","year":"2023","unstructured":"Matas M\u00e9ndez P, Fuentes Corripio I, Montoya Matute A, Bailo Barroso B, Grande G\u00f3mez R, Apruzzese Rubio A, et al. Prevalence of Toxoplasma gondii in endangered wild felines (Felis silvestris and Lynx pardinus) in Spain. Anim. 2023;13(15):2488. https:\/\/doi.org\/10.3390\/ANI13152488.","journal-title":"Anim"},{"key":"258_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/J.VETPAR.2020.109145","author":"JP Dubey","year":"2020","unstructured":"Dubey JP, Cerqueira-C\u00e9zar CK, Murata FHA, Kwok OCH, Yang YR, Su C. All about toxoplasmosis in cats: the last decade. Vet Parasitol. 2020. https:\/\/doi.org\/10.1016\/J.VETPAR.2020.109145.","journal-title":"Vet Parasitol"},{"issue":"1","key":"258_CR54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/CID\/CIU721","volume":"60","author":"M Opsteegh","year":"2015","unstructured":"Opsteegh M, Kortbeek TM, Havelaar AH, Van Der Giessen JWB. Intervention strategies to reduce human Toxoplasma gondii disease burden. Clin Infect Dis. 2015;60(1):101\u20137. https:\/\/doi.org\/10.1093\/CID\/CIU721.","journal-title":"Clin Infect Dis"},{"key":"258_CR55","unstructured":"Agencia Espa\u00f1ola de Seguridad Alimentaria. Aplicaci\u00f3n de radiaciones ionizantes a los alimentos. N Ref: AESA2003-004. Doc del Comit\u00e9 Cient\u00edfico, 22 septiembre 2004."},{"key":"258_CR56","first-page":"1","volume":"95","author":"RM Est\u00e9vez Reboredo","year":"2021","unstructured":"Est\u00e9vez Reboredo RM, Fuentes I, Carmona R, Cano PR. Toxoplasmosis en Espa\u00f1a, an\u00e1lisis de las hospitalizaciones en el periodo 1997\u20132018. Rev Esp Salud Publica. 2021;95:1\u201311.","journal-title":"Rev Esp Salud Publica"},{"issue":"3","key":"258_CR57","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4321\/S2173-92772023000300002","volume":"31","author":"M Gonz\u00e1lez-Viadero","year":"2023","unstructured":"Gonz\u00e1lez-Viadero M, Barba-S\u00e1nchez R, Gonz\u00e1lez-Barrio D, Fuentes I, Est\u00e9vez-Reboredo RM. Toxoplasmosis: estudio epidemiol\u00f3gico de hospitalizaci\u00f3n en Espa\u00f1a (2000\u20132021). BES. 2023;31(3):166\u201375. https:\/\/doi.org\/10.4321\/S2173-92772023000300002.","journal-title":"BES"},{"issue":"6","key":"258_CR58","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1111\/TBED.14758","volume":"69","author":"D Gonz\u00e1lez-Barrio","year":"2022","unstructured":"Gonz\u00e1lez-Barrio D, Carpio AJ, Sebasti\u00e1n-Pardo M, Peralbo-Moreno A, Ruiz-Fons F. The relevance of the wild reservoir in zoonotic multi-host pathogens: The links between Iberian wild mammals and Coxiella burnetii. Transbound Emerg Dis. 2022;69(6):3868\u201380. https:\/\/doi.org\/10.1111\/TBED.14758.","journal-title":"Transbound Emerg Dis"},{"issue":"8","key":"258_CR59","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/ZPH.12878","volume":"68","author":"S Castro-Scholten","year":"2021","unstructured":"Castro-Scholten S, Cano-Terriza D, Jim\u00e9nez-Ruiz S, Almer\u00eda S, Risalde MA, Vicente J, et al. Seroepidemiology of Toxoplasma gondii in wild ruminants in Spain. Zoonoses Public Health. 2021;68(8):884\u201395. https:\/\/doi.org\/10.1111\/ZPH.12878.","journal-title":"Zoonoses Public Health"},{"issue":"1","key":"258_CR60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0950-3552(05)80149-X","volume":"7","author":"B Stray-Pedersen","year":"1993","unstructured":"Stray-Pedersen B. Toxoplasmosis in pregnancy. Baillieres Clin Obstet Gynaecol. 1993;7(1):107\u201337. https:\/\/doi.org\/10.1016\/S0950-3552(05)80149-X.","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"258_CR61","doi-asserted-by":"publisher","unstructured":"de Fuentes Corripio, Isabel (coord.). Toxoplasmosis cong\u00e9nita en Espa\u00f1a, presente y futuro. Madrid; Instituto de Salud Carlos III, Centro Nacional de Microbiolog\u00eda, 2022. https:\/\/doi.org\/10.4321\/repisalud.15501. Disponible en: http:\/\/hdl.handle.net\/20.500.12105\/15501.","DOI":"10.4321\/repisalud.15501"},{"key":"258_CR62","volume-title":"Congenital toxoplasmosis","author":"AS Kota","year":"2023","unstructured":"Kota AS, Shabbir N. Congenital toxoplasmosis. StatPearls; 2023."},{"key":"258_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/PATHOGENS8010024","author":"F Peyron","year":"2019","unstructured":"Peyron F, L\u2019ollivier C, Mandelbrot L, Wallon M, Piarroux R, Kieffer F, et al. Maternal and congenital toxoplasmosis: diagnosis and treatment recommendations of a French Multidisciplinary Working Group. Pathog (Basel, Switzerland). 2019. https:\/\/doi.org\/10.3390\/PATHOGENS8010024.","journal-title":"Pathog (Basel, Switzerland)"},{"key":"258_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0273781","author":"L Sawers","year":"2022","unstructured":"Sawers L, Wallon M, Mandelbrot L, Villena I, Stillwaggon E, Kieffer F. Prevention of congenital toxoplasmosis in France using prenatal screening: a decision-analytic economic model. PLoS ONE. 2022. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0273781.","journal-title":"PLoS ONE"},{"key":"258_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/J.FAWPAR.2022.E00162","author":"E Petersen","year":"2022","unstructured":"Petersen E, Meroni V, Vasconcelos-Santos DV, Mandelbrot L, Peyron F. Congenital toxoplasmosis: should we still care about screening? Food Waterborne Parasitol. 2022. https:\/\/doi.org\/10.1016\/J.FAWPAR.2022.E00162.","journal-title":"Food Waterborne Parasitol."},{"key":"258_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-020-69078-9","author":"JJ Bigna","year":"2020","unstructured":"Bigna JJ, Tochie JN, Tounouga DN, Bekolo AO, Ymele NS, Youda EL, et al. Global, regional, and country seroprevalence of Toxoplasma gondii in pregnant women: a systematic review, modelling and meta-analysis. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/S41598-020-69078-9.","journal-title":"Sci Rep"},{"issue":"6","key":"258_CR67","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cmi.2020.01.008","volume":"26","author":"A Rostami","year":"2020","unstructured":"Rostami A, Riahi SM, Gamble HR, Fakhri Y, Nourollahpour Shiadeh M, Danesh M, et al. Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis. Clin Microbiol Infect. 2020;26(6):673\u201383. https:\/\/doi.org\/10.1016\/j.cmi.2020.01.008.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"258_CR68","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/INF.0000000000000006","volume":"33","author":"MG Capretti","year":"2014","unstructured":"Capretti MG, De Angelis M, Tridapalli E, Orlandi A, Marangoni A, Moroni A, et al. Toxoplasmosis in pregnancy in an area with low seroprevalence: is prenatal screening still worthwhile? Pediatr Infect Dis J. 2014;33(1):5\u201310. https:\/\/doi.org\/10.1097\/INF.0000000000000006.","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"258_CR69","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1080\/14767058.2018.1424822","volume":"32","author":"M Dalmartello","year":"2019","unstructured":"Dalmartello M, Parazzini F, Pedron M, Pertile R, Collini L, La Vecchia C, et al. Coverage and outcomes of antenatal tests for infections: a population based survey in the Province of Trento. Italy J Matern Fetal Neonatal Med. 2019;32(12):2049\u201355. https:\/\/doi.org\/10.1080\/14767058.2018.1424822.","journal-title":"Italy J Matern Fetal Neonatal Med"},{"issue":"5","key":"258_CR70","doi-asserted-by":"publisher","first-page":"1900710","DOI":"10.2807\/1560-7917.ES.2021.26.5.1900710\/CITE\/REFWORKS","volume":"26","author":"E Robinson","year":"2021","unstructured":"Robinson E, De Valk H, Villena I, Le Strat Y, Tourdjman M. National perinatal survey demonstrates a decreasing seroprevalence of Toxoplasma gondii infection among pregnant women in France, 1995 to 2016: Impact for screening policy. Eurosurveillance. 2021;26(5):1900710. https:\/\/doi.org\/10.2807\/1560-7917.ES.2021.26.5.1900710\/CITE\/REFWORKS.","journal-title":"Eurosurveillance"},{"issue":"3","key":"258_CR71","first-page":"59","volume":"64","author":"L Machala","year":"2015","unstructured":"Machala L, Kodym P, Mal\u00fd M, Geleneky M, Beran O, Jilich D. Toxoplasmosis in immunocompromised patients. Epidemiol Mikrobiol Imunol. 2015;64(3):59\u201365.","journal-title":"Epidemiol Mikrobiol Imunol"},{"key":"258_CR72","unstructured":"Unidad de vigilancia de VIH I y hepatitis. Vigilancia Epidemiol\u00f3gica del VIH y sida en Espa\u00f1a 2022: Sistema de Informaci\u00f3n sobre Nuevos Diagn\u00f3sticos de VIH y Registro Nacional de Casos de Sida. Cent Nac Epidemiol Inst Salud Carlos III\/ Div Control VIH, ITS, Hepat virales y Tuberc Minist Sanidad Madrid. 2023;"},{"issue":"3","key":"258_CR73","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/QAD.0000000000002424","volume":"34","author":"H Safarpour","year":"2020","unstructured":"Safarpour H, Cevik M, Zarean M, Barac A, Hatam-Nahavandi K, Rahimi MT, et al. Global status of Toxoplasma gondii infection and associated risk factors in people living with HIV. AIDS. 2020;34(3):469\u201374. https:\/\/doi.org\/10.1097\/QAD.0000000000002424.","journal-title":"AIDS"},{"issue":"1","key":"258_CR74","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0304-4858(00)74316-2","volume":"97","author":"J Mu\u00f1oz","year":"2000","unstructured":"Mu\u00f1oz J, Martinez P, Cubas L, Santamar\u00eda JM, Lamiquiz E, Teira R, et al. Supervivencia de los pacientes con sida en el Pa\u00eds Vasco antes de la terapia combinada. Gac M\u00e9dica Bilbao. 2000;97(1):5\u201310.","journal-title":"Gac M\u00e9dica Bilbao"},{"issue":"2","key":"258_CR75","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00436-020-07007-5","volume":"120","author":"M Menchi-Elanzi","year":"2021","unstructured":"Menchi-Elanzi M, Mayoral AM, Morales J, Pinargote-Celorio H, Gonz\u00e1lez-Alcaide G, Ramos-Rinc\u00f3n JM. Toxoplasma gondii infection in hospitalized people living with HIV in Spain, 1997 to 2015. Parasitol Res. 2021;120(2):755\u201361.","journal-title":"Parasitol Res"},{"issue":"2","key":"258_CR76","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1017\/S0950268800047993","volume":"105","author":"RE Holliman","year":"1990","unstructured":"Holliman RE. Serological study of the prevalence of toxoplasmosis in asymptomatic patients infected with human immunodeficiency virus. Epidemiol Infect. 1990;105(2):415. https:\/\/doi.org\/10.1017\/S0950268800047993.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"258_CR77","doi-asserted-by":"publisher","DOI":"10.1590\/0001-3765202020200293","volume":"92","author":"JC Moro","year":"2020","unstructured":"Moro JC, Moreira NM. Clinico-epidemiological and sociodemographic profile of HIV\/AIDS patients who are co-infected with Toxoplasma gondii in the border region of Brazil. An Acad Bras Cienc. 2020;92(4): e20200293. https:\/\/doi.org\/10.1590\/0001-3765202020200293.","journal-title":"An Acad Bras Cienc"},{"issue":"5","key":"258_CR78","doi-asserted-by":"publisher","first-page":"515","DOI":"10.4103\/IJMR.IJMR_110_19","volume":"152","author":"A Dutta","year":"2020","unstructured":"Dutta A, Mehta P, Ingole N. Seroprevalence of Toxoplasma gondii in newly diagnosed HIV seropositive patients. Indian J Med Res. 2020;152(5):515. https:\/\/doi.org\/10.4103\/IJMR.IJMR_110_19.","journal-title":"Indian J Med Res"},{"key":"258_CR79","doi-asserted-by":"publisher","unstructured":"Dian S, Rizal Ganiem A, Ekawardhani S. Cerebral toxoplasmosis in HIV-infected patients: a review. 2022; https:\/\/doi.org\/10.1080\/20477724.2022.2083977.","DOI":"10.1080\/20477724.2022.2083977"},{"key":"258_CR80","doi-asserted-by":"publisher","DOI":"10.1177\/23259582211043863","author":"A Lau","year":"2021","unstructured":"Lau A, Jain MK, Chow JYS, Kitchell E, Lazarte S, Nijhawan A. Toxoplasmosis encephalitis: a cross-sectional analysis at a U.S.Safety-Net Hospital in the Late cART Era. J Int Assoc Provid AIDS Care. 2021. https:\/\/doi.org\/10.1177\/23259582211043863.","journal-title":"J Int Assoc Provid AIDS Care."},{"key":"258_CR81","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/J.MICPATH.2019.01.040","volume":"129","author":"D Anvari","year":"2019","unstructured":"Anvari D, Sharif M, Sarvi S, Aghayan SA, Gholami S, Pagheh AS, et al. Seroprevalence of Toxoplasma gondii infection in cancer patients: a systematic review and meta-analysis. Microb Pathog. 2019;129:30\u201342. https:\/\/doi.org\/10.1016\/J.MICPATH.2019.01.040.","journal-title":"Microb Pathog"},{"issue":"7","key":"258_CR82","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.22034\/APJCP.2018.19.7.1987","volume":"19","author":"RA Malek","year":"2018","unstructured":"Malek RA, Wassef R, Rizk E, Sabry H, Tadros N, Boghdady A. Toxoplasmosis an overlooked disease: seroprevalence in cancer patients. Asian Pac J Cancer Prev. 2018;19(7):1987\u201391. https:\/\/doi.org\/10.22034\/APJCP.2018.19.7.1987.","journal-title":"Asian Pac J Cancer Prev"},{"key":"258_CR83","unstructured":"Est\u00e9vez Reboredo R, Carmona R, Cano Portero R. Toxoplasmosis cong\u00e9nita enfermedad de declaraci\u00f3n obligatoria (EDO), situaci\u00f3n actual en Espa\u00f1a. . In: Centro Nacional de Microbiolog\u00eda; Instituto de Salud Carlos III; Ministerio de Ciencia e Innovaci\u00f3n. Dise\u00f1o y maquetaci\u00f3n: Editorial MIC., editor. Toxoplasmosis cong\u00e9nita en Espa\u00f1a, presente y futuro Centro Nacional de Microbiolog\u00eda. 2022 [cited 2024 Mar 12]. pp. 11\u20135."},{"issue":"3","key":"258_CR84","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/jrsm.1547","volume":"13","author":"CB Migliavaca","year":"2022","unstructured":"Migliavaca CB, Stein C, Colpani V, Barker TH, Ziegelmann PK, Munn Z, Falavigna M. Prevalence Estimates Reviews-Systematic Review Methodology Group (PERSyst). Meta-analysis of prevalence: I2 statistic and how to deal with heterogeneity. Res Synth Methods. 2022;13(3):363\u20137. https:\/\/doi.org\/10.1002\/jrsm.1547.","journal-title":"Res Synth Methods."}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-024-00258-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-024-00258-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-024-00258-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T06:10:39Z","timestamp":1727676639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-024-00258-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":84,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["258"],"URL":"https:\/\/doi.org\/10.1007\/s44197-024-00258-w","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest."}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}